Amniotics AB
Lund, SE· latest recorded location
Amniotics AB is named on 6 US grants and 14 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 6
- Published applications
- 14
- Inventors
- 12
- Granted in 2026 so far
- 1
- Most recent grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 5 |
| 2023 | 1 | 2 |
| 2024 | 0 | 3 |
| 2025 | 2 | 1 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 20 documents
- C12NMicroorganisms or enzymes15
- A61KMedicines and medical preparations10
- A61PTherapeutic uses of medicines9
- Y02ATechnologies for adaptation to climate change4
- A61BMedical diagnosis and surgery3
- A61MDevices for delivering substances into the body3
- B01DSeparation2
- A01NPreservation of bodies of humans or animals or plants or parts thereof1
- C07KPeptides1
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
Recent patents
- Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof30 Jun 2026US 12,667,593 B2
- Apparatus for filtering amniotic fluid11 Nov 2025US 12,465,878 B2
- Immunomodulation by amniotic fluid mesenchymal stem cells7 Oct 2025US 12,435,308 B2
- Methods and compositions for generating hematopoietic cells3 Jan 2023US 11,542,473 B2
- Use of term amniotic fluid cells for the treatment of acute and chronic respiratory diseases20 Sep 2022US 11,446,334 B2
- Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof1 Oct 2026US 2026/0294976 A1
- A method of producing extracellular vesicles14 May 2026US 2026/0130942 A1
- Lineage specification during stem cell transition24 Apr 2025US 2025/0129334 A1
- Mesenchymal stem cells for use in increasing ex-vivo organ life23 May 2024US 2024/0164369 A1
- Stem cells for use in reducing the immune response following organ transplantation23 May 2024US 2024/0165164 A1
Most cited
By later US patents